List view / Grid view
18 January 2019 | By Henning Gieseler, Julia Kosan
Scale-up of pharmaceutical freeze-drying processes is cost and time consuming due to Quality by Design (QbD) requirements and novel compound costs or availability. The application of placebo formulations offers a promising way to improve drug development activities and save resources. Furthermore, placebos are used as a reference in clinical trials.…
20 November 2018 | By ACD/Labs
Luminata enables assembly of a complete impurity control strategy for pharmaceutical development...
26 June 2018 | By Kaiser Optical Systems
Bioprocesses require automated process control to make quality products consistently and efficiently...
25 June 2018 | By European Pharmaceutical Review
In this issue: the applications of vibrational spectroscopy for analysing the molecular component of a solid sample, and Raman as a fast-growing tool for PAT/QbD
22 June 2018 | By AdvantaPure
Provides Drug Manufacturers with Extensive Test Results for Tubing Comparison...
26 February 2018 | By Perceptive Engineering
Siemens AG and Perceptive Engineering Ltd announce a partnership which offers Perceptive’s PharmaMV and Siemens Simatic Sipat software products closely integrated to provide a versatile solution for advanced control and optimisation applications in both continuous and batch pharmaceutical manufacturing...
17 January 2018 | By Gilberto Dalmaso and Frank Panofen - Particle Measuring Systems
Quality by Design (QbD) is a method approach to developing a quality control system using predetermined objectives. It uses the foundations of risk management and science to ensure a repeatable process to manufacture high-quality products. In 2002, the FDA launched QbD as part of its innovation initiative. This paper outlines…
15 January 2018 | By European Pharmaceutical Review
This In-Depth Focus looks at QbD and PAT for cutting biopharma attrition rates as well as continuous freeze-drying technology for biopharma products...
18 December 2017 | By Chris Edlin, Darren Whitaker
Pharmaceutical manufacturing in the modern era is facing unprecedented demands, including in-depth scrutiny of production methodology, and inefficiencies in current practices with respect to waste, energy usage and time management. Coupling this with increased complexity in the manufacture of newer products and the decline of blockbuster drugs, results in an…
15 December 2017 | By Arathi Kizhedath, Jarka Glassey
QbD and PAT could revolutionise the way biopharma industries operate by cutting down their attrition rates, which could drastically change their business model. This article considers the issues involved.
14 November 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
In April 2018, changes to energy efficiency regulations will mean that every non-domestic privately rented property must have an EPC rating of at least an E. Here, John Rush, discusses three tips for improving the energy efficiency of HVAC systems in laboratories...
17 October 2017 | By European Pharmaceutical Review
In this issue: Sample preparation - is it possible to have too much? Developing successful over-the-counter syrup packaging for the highly regulated EU market. In-line process PAT in continous wet granulation, and much more...
2 August 2017 | By Tecan
Tecan has introduced a selection of clear Liquid Handling (LiHa) disposable tips*, creating a one-stop shop for all your disposable tip needs...
3 July 2017 | By Joe Principe | Vice President of Strategic Partnerships | Patheon
Patheon’s Joe Principe examines current trends in outsourcing, highlighting the importance of investment in CDMO partnerships...
29 June 2017 | By ACD/Labs
ACD/Labs discuss two software systems that enables systematic and exhaustive approach towards method development and captures structural, analytical, and process related data...
Follow: